AGF Investments Inc’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $45M | Sell |
471,822
-7,927
| -2% | -$785K | 0.43% | 79 |
|
|
2022
Q2 | $44.5M | Buy |
479,749
+3,855
| +0.8% | +$376K | 0.4% | 91 |
|
|
2022
Q1 | $48.2M | Sell |
475,894
-39,188
| -8% | -$4.12M | 0.36% | 91 |
|
|
2021
Q4 | $53.1M | Sell |
515,082
-53,885
| -9% | -$4.98M | 0.38% | 88 |
|
|
2021
Q3 | $48.3M | Sell |
568,967
-146,063
| -20% | -$12.2M | 0.37% | 98 |
|
|
2021
Q2 | $59.7M | Sell |
715,030
-11,131
| -2% | -$912K | 0.45% | 84 |
|
|
2021
Q1 | $54.6M | Sell |
726,161
-35,807
| -5% | -$2.61M | 0.43% | 84 |
|
|
2020
Q4 | $52M | Sell |
761,968
-31,358
| -4% | -$2.04M | 0.44% | 86 |
|
|
2020
Q3 | $46.3M | Sell |
793,326
-163,091
| -17% | -$10.1M | 0.47% | 74 |
|
|
2020
Q2 | $62.1M | Sell |
956,417
-6,713
| -0.7% | -$423K | 0.66% | 47 |
|
|
2020
Q1 | $57.1M | Buy |
963,130
+335,153
| +53% | +$22.4M | 0.69% | 44 |
|
|
2019
Q4 | $46.7M | Buy |
627,977
+1,754
| +0.3% | +$123K | 0.56% | 62 |
|
|
2019
Q3 | $39.5M | Buy |
626,223
+2,356
| +0.4% | +$140K | 0.5% | 72 |
|
|
2019
Q2 | $34M | Buy |
623,867
+3,267
| +0.5% | +$176K | 0.41% | 87 |
|
|
2019
Q1 | $33.5M | Buy |
620,600
+184,590
| +42% | +$11.4M | 0.38% | 87 |
|
|
2018
Q4 | $28.6M | Buy |
436,010
+117,496
| +37% | +$8.77M | 0.34% | 94 |
|
|
2018
Q3 | $25.1M | Hold |
318,514
| – | – | 0.25% | 115 |
|
|
2018
Q2 | $20.5M | Sell |
318,514
-6,000
| -2% | -$395K | 0.21% | 127 |
|
|
2018
Q1 | $20.2M | Buy |
324,514
+6,000
| +2% | +$430K | 0.22% | 124 |
|
|
2017
Q4 | $23.1M | Buy |
318,514
+13,439
| +4% | +$977K | 0.22% | 127 |
|
|
2017
Q3 | $24.8M | Hold |
305,075
| – | – | 0.27% | 107 |
|
|
2017
Q2 | $24.5M | Buy |
305,075
+23,563
| +8% | +$1.86M | 0.28% | 97 |
|
|
2017
Q1 | $22.1M | Buy |
281,512
+17,162
| +6% | +$1.37M | 0.24% | 122 |
|
|
2016
Q4 | $20.8M | Buy |
264,350
+59,772
| +29% | +$4.84M | 0.24% | 121 |
|
|
2016
Q3 | $18.2M | Sell |
204,578
-8,595
| -4% | -$811K | 0.2% | 135 |
|
|
2016
Q2 | $20.4M | Buy |
213,173
+32,914
| +18% | +$3.28M | 0.23% | 122 |
|
|
2016
Q1 | $18.7M | Sell |
180,259
-28,544
| -14% | -$2.78M | 0.23% | 122 |
|
|
2015
Q4 | $20.4M | Sell |
208,803
-7,400
| -3% | -$725K | 0.25% | 120 |
|
|
2015
Q3 | $20.9M | Sell |
216,203
-129,185
| -37% | -$13.6M | 0.26% | 114 |
|
|
2015
Q2 | $36.2M | Buy |
345,388
+4,300
| +1% | +$439K | 0.39% | 85 |
|
|
2015
Q1 | $35.2M | Sell |
341,088
-6,300
| -2% | -$637K | 0.38% | 89 |
|
|
2014
Q4 | $33.4M | Sell |
347,388
-88,100
| -20% | -$7.76M | 0.36% | 99 |
|
|
2014
Q3 | $34.7M | Sell |
435,488
-8,400
| -2% | -$662K | 0.36% | 103 |
|
|
2014
Q2 | $33.5M | Sell |
443,888
-1,900
| -0.4% | -$144K | 0.33% | 111 |
|
|
2014
Q1 | $33.4M | Sell |
445,788
-14,200
| -3% | -$1M | 0.34% | 106 |
|
|
2013
Q4 | $33M | Buy |
459,988
+54,500
| +13% | +$3.5M | 0.34% | 97 |
|
|
2013
Q3 | $23M | Buy |
405,488
+38,000
| +10% | +$2.26M | 0.26% | 123 |
|
|
2013
Q2 | $21M | Buy |
+367,488
| New | +$21.3M | 0.24% | 123 |
|
Other funds holding CVS
AGF Investments Inc's CVS Position: Q3 2022 in Review
AGF Investments Inc reduced its CVS Health (CVS) stake by 1.7% in Q3 2022, selling an estimated $785K and leaving 471,822 shares worth $45M. The position accounts for 0.43% of the portfolio, ranked #79.
AGF Investments Inc first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $62.1M in Q2 2020. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- AGF Investments Inc held 471,822 shares of CVS Health worth $45M as of Q3 2022.
- AGF Investments Inc sold 7,927 CVS Health shares in Q3 2022, an estimated $785K.
- CVS Health made up 0.43% of AGF Investments Inc's portfolio in Q3 2022, its #79 holding.
- AGF Investments Inc first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- AGF Investments Inc's CVS Health position peaked at $62.1M in Q2 2020.
- 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.